Donald Scott McLeod, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Neoplasms | 15 | 2022 | 2360 | 2.230 |
Why?
|
| Carcinoma, Papillary | 3 | 2020 | 793 | 0.920 |
Why?
|
| Iodine Radioisotopes | 5 | 2022 | 1034 | 0.750 |
Why?
|
| Hyperthyroidism | 1 | 2022 | 293 | 0.680 |
Why?
|
| Thyroid Diseases | 1 | 2022 | 385 | 0.620 |
Why?
|
| Hypothyroidism | 1 | 2022 | 668 | 0.560 |
Why?
|
| Thyrotoxicosis | 1 | 2015 | 85 | 0.470 |
Why?
|
| Vitamin D | 10 | 2023 | 3311 | 0.460 |
Why?
|
| Mexican Americans | 1 | 2015 | 165 | 0.460 |
Why?
|
| Autoimmunity | 1 | 2022 | 1360 | 0.450 |
Why?
|
| Thyrotropin | 2 | 2015 | 834 | 0.450 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2015 | 327 | 0.440 |
Why?
|
| Australia | 12 | 2023 | 1265 | 0.430 |
Why?
|
| Hypercalcemia | 1 | 2015 | 424 | 0.390 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2015 | 326 | 0.390 |
Why?
|
| Dietary Supplements | 9 | 2023 | 3442 | 0.370 |
Why?
|
| Thyroid Gland | 1 | 2015 | 1172 | 0.310 |
Why?
|
| Vitamins | 8 | 2023 | 1638 | 0.310 |
Why?
|
| Ultraviolet Rays | 2 | 2022 | 1104 | 0.280 |
Why?
|
| Queensland | 6 | 2021 | 53 | 0.260 |
Why?
|
| Antithyroid Agents | 2 | 2016 | 72 | 0.260 |
Why?
|
| Vitamin D Deficiency | 3 | 2022 | 1388 | 0.220 |
Why?
|
| Prealbumin | 3 | 2023 | 259 | 0.220 |
Why?
|
| Trophoblasts | 2 | 2022 | 223 | 0.210 |
Why?
|
| Thyroidectomy | 2 | 2019 | 914 | 0.200 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2021 | 2059 | 0.180 |
Why?
|
| Cholecalciferol | 5 | 2023 | 557 | 0.180 |
Why?
|
| Combat Disorders | 1 | 2001 | 301 | 0.160 |
Why?
|
| Diseases in Twins | 1 | 2001 | 447 | 0.160 |
Why?
|
| Thyroxine | 1 | 2022 | 665 | 0.150 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2018 | 85 | 0.150 |
Why?
|
| Receptors, Lipoprotein | 1 | 2018 | 88 | 0.150 |
Why?
|
| Lymphatic Metastasis | 3 | 2020 | 2916 | 0.140 |
Why?
|
| Incidence | 7 | 2022 | 21545 | 0.140 |
Why?
|
| Hysterectomy | 1 | 2021 | 866 | 0.130 |
Why?
|
| Methimazole | 1 | 2015 | 41 | 0.130 |
Why?
|
| Propylthiouracil | 1 | 2015 | 68 | 0.120 |
Why?
|
| Environment | 1 | 2001 | 1125 | 0.120 |
Why?
|
| Graves Disease | 1 | 2016 | 239 | 0.120 |
Why?
|
| Humans | 37 | 2023 | 768887 | 0.120 |
Why?
|
| Neoplasms | 3 | 2022 | 22390 | 0.120 |
Why?
|
| Antibodies | 1 | 2022 | 2422 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2023 | 2820 | 0.110 |
Why?
|
| Lipoproteins, HDL | 1 | 2018 | 682 | 0.110 |
Why?
|
| Accidental Falls | 1 | 2021 | 1080 | 0.110 |
Why?
|
| Aged | 18 | 2023 | 171790 | 0.110 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 1251 | 0.110 |
Why?
|
| Patient Preference | 1 | 2021 | 947 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2021 | 1014 | 0.100 |
Why?
|
| Placenta | 2 | 2022 | 1721 | 0.100 |
Why?
|
| Terminology as Topic | 1 | 2019 | 1541 | 0.090 |
Why?
|
| Double-Blind Method | 5 | 2023 | 12469 | 0.090 |
Why?
|
| Case-Control Studies | 4 | 2022 | 22294 | 0.090 |
Why?
|
| Amyloidosis | 1 | 2019 | 879 | 0.090 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 1260 | 0.090 |
Why?
|
| Alcoholism | 1 | 2001 | 1981 | 0.090 |
Why?
|
| Adult | 14 | 2022 | 223818 | 0.080 |
Why?
|
| Female | 19 | 2023 | 397464 | 0.080 |
Why?
|
| Logistic Models | 3 | 2021 | 13317 | 0.080 |
Why?
|
| Age of Onset | 1 | 2015 | 3346 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2021 | 24330 | 0.070 |
Why?
|
| Survival Rate | 3 | 2019 | 12873 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2015 | 1738 | 0.070 |
Why?
|
| Male | 15 | 2023 | 365249 | 0.070 |
Why?
|
| Carcinoma | 1 | 2019 | 2340 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2020 | 6434 | 0.060 |
Why?
|
| Middle Aged | 11 | 2021 | 223740 | 0.060 |
Why?
|
| Age Factors | 3 | 2019 | 18454 | 0.060 |
Why?
|
| Prognosis | 2 | 2015 | 30044 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7472 | 0.060 |
Why?
|
| Anxiety | 1 | 2019 | 4677 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 5544 | 0.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2001 | 4642 | 0.050 |
Why?
|
| Depression | 1 | 2023 | 8240 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 5864 | 0.050 |
Why?
|
| Young Adult | 6 | 2021 | 60110 | 0.050 |
Why?
|
| Prevalence | 2 | 2019 | 15875 | 0.050 |
Why?
|
| Calcium | 1 | 2015 | 5792 | 0.050 |
Why?
|
| Biosensing Techniques | 1 | 2008 | 662 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2008 | 1124 | 0.050 |
Why?
|
| Adolescent | 6 | 2021 | 89247 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11262 | 0.040 |
Why?
|
| Vietnam | 1 | 2001 | 415 | 0.040 |
Why?
|
| Calcifediol | 1 | 2021 | 160 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2008 | 2149 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2023 | 559 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 18065 | 0.040 |
Why?
|
| Pregnancy | 4 | 2023 | 30175 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2023 | 642 | 0.040 |
Why?
|
| Disease-Free Survival | 2 | 2019 | 6856 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2001 | 1002 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2021 | 65485 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2022 | 876 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2001 | 993 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 13087 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2020 | 1183 | 0.040 |
Why?
|
| Risk | 2 | 2020 | 9621 | 0.040 |
Why?
|
| Quality of Life | 1 | 2019 | 13510 | 0.040 |
Why?
|
| Nicotine | 1 | 2022 | 681 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2008 | 3138 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2021 | 498 | 0.030 |
Why?
|
| Nanoparticles | 1 | 2008 | 1989 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15662 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2023 | 1246 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 10397 | 0.030 |
Why?
|
| Mutation | 1 | 2020 | 30266 | 0.030 |
Why?
|
| England | 1 | 2016 | 533 | 0.030 |
Why?
|
| Smoking | 2 | 2022 | 9094 | 0.030 |
Why?
|
| Estrogens | 1 | 2021 | 1537 | 0.030 |
Why?
|
| Fasting | 1 | 2020 | 1610 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2001 | 2730 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 26384 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 10778 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 1608 | 0.030 |
Why?
|
| Focus Groups | 1 | 2019 | 1461 | 0.030 |
Why?
|
| Risk Factors | 2 | 2015 | 74971 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2023 | 4032 | 0.020 |
Why?
|
| Child | 2 | 2023 | 80969 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 4123 | 0.020 |
Why?
|
| United States | 2 | 2015 | 73180 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2017 | 2663 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2019 | 2742 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2001 | 3446 | 0.020 |
Why?
|
| Ligands | 1 | 2018 | 3283 | 0.020 |
Why?
|
| Rats | 2 | 2022 | 23847 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2019 | 81892 | 0.020 |
Why?
|
| Overweight | 1 | 2020 | 2445 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2019 | 3143 | 0.020 |
Why?
|
| Pain | 1 | 2022 | 5100 | 0.020 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2008 | 209 | 0.020 |
Why?
|
| Response Elements | 1 | 2008 | 308 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2001 | 5107 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2008 | 1163 | 0.020 |
Why?
|
| Health Status | 1 | 2019 | 4095 | 0.020 |
Why?
|
| Cognition | 1 | 2023 | 7080 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 8055 | 0.010 |
Why?
|
| Registries | 1 | 2001 | 8384 | 0.010 |
Why?
|
| Cell Line | 1 | 2018 | 15603 | 0.010 |
Why?
|
| Phenotype | 1 | 2001 | 16735 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 1209 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2020 | 13054 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 1973 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5707 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5520 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2023 | 59738 | 0.010 |
Why?
|
| Glucose | 1 | 2008 | 4352 | 0.010 |
Why?
|
| Animals | 2 | 2022 | 169408 | 0.010 |
Why?
|
| Mitochondria | 1 | 2008 | 3683 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 19023 | 0.010 |
Why?
|